Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketan N Malu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of the Association of Physicians of India|September 2, 2021
The Case Against TocilizumabZarir Udwadia, Ketan N Malu, Awatansh Kumar R Tripathi
The Journal of the Association of Physicians of India|July 3, 2020
Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?Zarir F Udwadia, Ketan N Malu, Divyanshi Rana, et al.
The Indian Journal of Tuberculosis|December 14, 2020
COVID-19 -Tuberculosis interactions: When dark forces collideZarir F Udwadia, Agam Vora, Awatansh R Tripathi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of the Association of Physicians of India|September 2, 2021
The Case Against TocilizumabZarir Udwadia, Ketan N Malu, Awatansh Kumar R Tripathi
The Journal of the Association of Physicians of India|July 3, 2020
Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?Zarir F Udwadia, Ketan N Malu, Divyanshi Rana, et al.
The Indian Journal of Tuberculosis|December 14, 2020
COVID-19 -Tuberculosis interactions: When dark forces collideZarir F Udwadia, Agam Vora, Awatansh R Tripathi, et al.
Pageof 1